BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18524572)

  • 1. Structure/function of the inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane.
    Thomas JL; Mack VL; Glow JA; Moshkelani D; Terrell JR; Bucholtz KM
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):66-73. PubMed ID: 18524572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis.
    Thomas JL; Mack VL; Sun J; Terrell JR; Bucholtz KM
    J Steroid Biochem Mol Biol; 2010 Jun; 120(4-5):192-9. PubMed ID: 20420909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationships for the selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 by a novel androgen analog.
    Pham JH; Will CM; Mack VL; Halbert M; Conner EA; Bucholtz KM; Thomas JL
    J Steroid Biochem Mol Biol; 2017 Nov; 174():257-264. PubMed ID: 29031687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key amino acids responsible for the substantially higher affinities of human type 1 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD1) for substrates, coenzymes, and inhibitors relative to human 3beta-HSD2.
    Thomas JL; Boswell EL; Scaccia LA; Pletnev V; Umland TC
    J Biol Chem; 2005 Jun; 280(22):21321-8. PubMed ID: 15797861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells.
    Thomas JL; Bucholtz KM; Sun J; Mack VL; Kacsoh B
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):174-82. PubMed ID: 18955108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.
    Thomas JL; Bucholtz KM; Kacsoh B
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):57-65. PubMed ID: 20736065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The higher affinity of human type 1 3beta-hydroxysteroid dehydrogenase (3beta-HSD1) for substrate and inhibitor steroids relative to human 3beta-HSD2 is validated in MCF-7 tumor cells and related to subunit interactions.
    Thomas JL; Umland TC; Scaccia LA; Boswell EL; Kacsoh B
    Endocr Res; 2004 Nov; 30(4):935-41. PubMed ID: 15666848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine 124 completes the Tyr, Lys and Ser triad responsible for the catalysis of human type 1 3beta-hydroxysteroid dehydrogenase.
    Thomas JL; Duax WL; Addlagatta A; Scaccia LA; Frizzell KA; Carloni SB
    J Mol Endocrinol; 2004 Aug; 33(1):253-61. PubMed ID: 15291757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity.
    Thomas JL; Mason JI; Brandt S; Spencer BR; Norris W
    J Biol Chem; 2002 Nov; 277(45):42795-801. PubMed ID: 12205101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure/function aspects of human 3beta-hydroxysteroid dehydrogenase.
    Thomas JL; Duax WL; Addlagatta A; Kacsoh B; Brandt SE; Norris WB
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):73-82. PubMed ID: 15026177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
    Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/function of human type 1 3beta-hydroxysteroid dehydrogenase: An intrasubunit disulfide bond in the Rossmann-fold domain and a Cys residue in the active site are critical for substrate and coenzyme utilization.
    Thomas JL; Huether R; Mack VL; Scaccia LA; Stoner RC; Duax WL
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):80-7. PubMed ID: 17624763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3beta-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice.
    Espallergues J; Givalois L; Temsamani J; Laruelle C; Maurice T
    Psychoneuroendocrinology; 2009 Jun; 34(5):644-59. PubMed ID: 19117688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
    Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
    Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib.
    Lin JC; Liu CL; Chang YC; Cheng SP; Huang WC; Lin CH; Wu CY; Chen MJ
    Invest New Drugs; 2021 Dec; 39(6):1493-1506. PubMed ID: 34031786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
    Han H; Thériault JF; Chen G; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():36-45. PubMed ID: 28554725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors.
    Espallergues J; Temsamani J; Laruelle C; Urani A; Maurice T
    Psychopharmacology (Berl); 2011 Mar; 214(2):455-63. PubMed ID: 20981412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of trilostane and cyanoketone on the 3 beta-hydroxysteroid dehydrogenase-isomerase reactions in androgen and 16-androstene biosynthetic pathways in the pig testis.
    Cooke GM
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):95-101. PubMed ID: 8809191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutagenesis identifies amino acid residues associated with the dehydrogenase and isomerase activities of human type I (placental) 3beta-hydroxysteroid dehydrogenase/isomerase.
    Thomas JL; Evans BW; Blanco G; Mercer RW; Mason JI; Adler S; Nash WE; Isenberg KE; Strickler RC
    J Steroid Biochem Mol Biol; 1998 Sep; 66(5-6):327-34. PubMed ID: 9749838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational proteomics V: structure-based mutagenesis has revealed key residues responsible for substrate recognition and catalysis by the dehydrogenase and isomerase activities in human 3beta-hydroxysteroid dehydrogenase/isomerase type 1.
    Pletnev VZ; Thomas JL; Rhaney FL; Holt LS; Scaccia LA; Umland TC; Duax WL
    J Steroid Biochem Mol Biol; 2006 Sep; 101(1):50-60. PubMed ID: 16889958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.